GILGAMESH PHARMACEUTICALS
Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy. Mental health worldwide has reached epidemic proportions and novel treatments have not kept pace with the urgent need to treat depression, anxiety, drug addiction and many other devastating diseases. Our purpose is to accelerate treatments and fundamentally improve mental health.
GILGAMESH PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2019-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.gilgameshpharmaceutical.com
Total Employee:
11+
Status:
Active
Total Funding:
29.56 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Global Site Tag
Similar Organizations
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Praxis Precision Medicines
Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
Founder
Investors List
What If Ventures
What If Ventures investment in Series A - Gilgamesh Pharmaceuticals
Gaingels
Gaingels investment in Series A - Gilgamesh Pharmaceuticals
Palo Alto Investors
Palo Alto Investors investment in Series A - Gilgamesh Pharmaceuticals
Route 66 Ventures
Route 66 Ventures investment in Series A - Gilgamesh Pharmaceuticals
JLS Fund
JLS Fund investment in Series A - Gilgamesh Pharmaceuticals
Prime Movers Lab
Prime Movers Lab investment in Series A - Gilgamesh Pharmaceuticals
Alumni Ventures
Alumni Ventures investment in Series A - Gilgamesh Pharmaceuticals
Gron Ventures
Gron Ventures investment in Series A - Gilgamesh Pharmaceuticals
Noetic Fund
Noetic Fund investment in Series A - Gilgamesh Pharmaceuticals
Aera VC
Aera VC investment in Seed Round - Gilgamesh Pharmaceuticals
Official Site Inspections
http://www.gilgameshpharmaceutical.com Semrush global rank: 4.35 M Semrush visits lastest month: 2.61 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Gilgamesh Pharmaceuticals"
Gilgamesh Pharmaceuticals - Wikipedia
Gilgamesh Pharmaceuticals is a pharmaceutical company that is developing psychedelic and related drugs as medicines. It is a "discovery stage" company and is focused on developing new chemical entities. Its drug candidates include the ketamine-related NMDA receptor antagonist blixeprodil (GM-1020; (R)-4-fluorodeschloroketamine or (R)-4-FDCK), the dimethyltryptamineSee details»
Gilgamesh Pharmaceuticals - Crunchbase Company Profile
Gilgamesh Pharmaceuticals provides medicines for psychedelic, novel psychotropic drugs, depression, anxiety, and stress-related disorders.See details»
Gilgamesh Pharmaceuticals Inc Company Profile | New York, NY ...
Find company research, competitor information, contact details & financial data for Gilgamesh Pharmaceuticals Inc of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Gilgamesh Pharmaceuticals - Overview, News & Similar
Dec 14, 2022 View Gilgamesh Pharmaceuticals (www.gilgameshpharmaceutical.com) location in New York, United States , revenue, industry and description. Find related and similar …See details»
Gilgamesh Pharmaceuticals - Leadership Team | The Org
The Leadership Team at Gilgamesh Pharmaceuticals is responsible for guiding the strategic direction and overall vision of the company. Comprising co-founders with expertise in …See details»
Gilgamesh Pharmaceuticals - Work in biotech
Gilgamesh Pharmaceuticals is a clinical-stage neuroscience biotech company focused on developing innovative, rapid-acting, and long-lasting therapies for psychiatric disorders. Their …See details»
Gilgamesh Pharmaceuticals Company Information - Funding, …
Gilgamesh Pharmaceuticals is a pharmaceutical platform company developing an oral arylcyclohexylamine therapeutic and the next generation of psychedelic-related medicines.See details»
Gilgamesh Pharmaceuticals - LinkedIn
Gilgamesh Pharmaceuticals | 7,066 followers on LinkedIn. Gilgamesh is a clinical-stage biotech whose vision is to reshape how mental illnesses are treated by shifting away from symptom …See details»
About - Gilgamesh Pharmaceutical
Gilgamesh's discovery platform provides a state-of-the-art neurocircuitry-focused translational approach to novel drug candidate optimization and selection. The platform aims to identify …See details»
Gilgamesh Pharmaceuticals Company Profile | Management and
Gilgamesh Pharmaceuticals Profile and History Gilgamesh is a pioneering, mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new …See details»
Gilgamesh Pharmaceuticals 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Gilgamesh Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Gilgamesh Pharmaceuticals - Y Combinator
Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company…. Founded in 2019 by Andrew Kruegel, Dalibor Sames, and JONATHAN SPORN, Gilgamesh Pharmaceuticals has …See details»
Gilgamesh Pharmaceutical
Https://www.gilgameshpharmaceutical.com Type: Privately Held Focus: Ketamine Location: New York, New York, USA People: Jonathan Sporn (CEO) Investors: The Conscious Fund Y …See details»
Gilgamesh Pharmaceuticals Closes On $27 Million Series A Round
NEW YORK, May 6, 2021 /PRNewswire/ — Gilgamesh Pharmaceuticals, a mental health science focused biotechnology company utilizing psychedelic-related medicines for the treatment of …See details»
Gilgamesh Pharmaceuticals - F6S
Gilgamesh is a discovery and early development biotech company developing small molecules complemented by biomarkers to treat mental illness. The company leverages deep expertise …See details»
Contact Us - Gilgamesh Pharmaceutical
113 University Place, Suite 1019, NY, NY 10003 [email protected]See details»
Team - Gilgamesh Pharmaceutical
Leadership Team We’re a team of world-class scientists, medicinal chemists, inventors and leaders from top academic and biopharmaceutical institutions, tackling the hardest mental …See details»
Gilgamesh Pharmaceuticals Announces Positive Topline Phase
23 hours ago NEW YORK, May 27, 2025 /PRNewswire/ -- Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company developing innovative, best-in-class new chemical …See details»
Mental health biotech startup Gilgamesh Pharmaceuticals closes …
May 7, 2021 Gilgamesh Pharmaceuticals, a mental health science focused biotechnology company utilizing psychedelic-related medicines for the treatment of neuropsychiatric …See details»
Gilgamesh Pharmaceuticals Announces Positive Topline Phase 2a …
1 day ago GM-2505, a novel 5-HT2A receptor agonist and 5-HT releaser, demonstrated rapid, robust, and durable antidepressant effect in MDD Demonstrated robust...See details»